Why are CJC-1295 and ipamorelin often studied together?

They act on different receptor pathways: CJC-1295 via GHRH receptors and ipamorelin via ghrelin receptors. Research data shows the combination produces synergistic GH pulses compared to either compound alone, which is why the stack appears frequently in GH axis research literature.

Is ipamorelin or CJC-1295 better for GH research?

They are complementary rather than interchangeable. CJC-1295 sustains elevated GHRH signaling while ipamorelin provides precise GH pulse control with minimal cortisol or prolactin effect in research models. The "better" choice depends on your specific research endpoint.

Where can I find CJC-1295 and ipamorelin for research?

Research-grade CJC-1295 and ipamorelin are available through research peptide suppliers. Use code SOL at Live Alpha Labs for 10% off. For research use only. We may earn from qualifying purchases.

GH secretagogue comparison

CJC-1295 vs Ipamorelin: Research Comparison

Short answer: CJC-1295 is a GHRH analog (pituitary GHRH receptor); ipamorelin is a GHRP (ghrelin/GHSR receptor). They target different pathways and are frequently studied in combination because their mechanisms are synergistic — not redundant.

Disclosure: This page contains affiliate links. We may earn from qualifying purchases. See our full disclosure.

CJC-1295GHRH analog

Mechanism: GHRH receptor agonist — stimulates pituitary GH release via GHRH pathway
Structure: 30-amino-acid GHRH analog; DAC variant includes drug affinity complex for extended half-life
Half-life context: CJC-1295 without DAC ~30 min; with DAC ~8 days
Research profile: Consistent GH elevation with preserved pulsatility when DAC-free form is used
Selectivity: Selective for GHRH receptor; minimal cortisol and prolactin effects in research models
Common research pairing: Frequently studied with ipamorelin for synergistic GH output

IpamorelinGHRP / Ghrelin mimetic

Mechanism: Ghrelin receptor (GHSR-1a) agonist — stimulates GH release via ghrelin pathway
Structure: 5-amino-acid synthetic peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
Half-life context: ~2 hours — produces precise, transient GH pulses
Research profile: High GH selectivity with minimal effect on cortisol, prolactin, and ACTH in research models
Selectivity: Most selective GHRP in the published literature by cortisol/prolactin ratio
Common research pairing: Frequently studied with CJC-1295 for dual-pathway GH stimulation

Mechanism Comparison at a Glance

Criteria	CJC-1295	Ipamorelin
Receptor target	GHRH receptor	Ghrelin/GHSR receptor
GH effect	Sustained elevation	Precise, controlled pulses
Cortisol/prolactin effect	Minimal	Minimal (most selective GHRP)
Research use case	GHRH axis studies	Ghrelin pathway + selective GH

Current research deal — use code SOL

10% off CJC-1295 and ipamorelin research compounds at Live Alpha Labs. Credit cards accepted. For research use only. We may earn from qualifying purchases.

Claim 10% off at Live Alpha →View Deals Hub

Brand comparison

Best Ipamorelin Peptide Brand

Related compound

Best Sermorelin Peptide Brand

Category hub

Hormone and Endocrine Research Hub

All current offers

Peptide Deals + Research News Hub

Frequently Asked Questions

CJC-1295 is a GHRH (growth hormone releasing hormone) analog that stimulates the pituitary to release GH via GHRH receptors. Ipamorelin is a GHRP (growth hormone releasing peptide) that acts via the ghrelin receptor (GHSR). They target different upstream pathways that converge on GH release — which is why research frequently studies them together.

CJC-1295 vs Ipamorelin: Research Comparison

Disclosure: This page contains affiliate links. We may earn from qualifying purchases. See our full disclosure.

Criteria

CJC-1295

Ipamorelin

Receptor target

GHRH receptor

Ghrelin/GHSR receptor

GH effect

Sustained elevation

Precise, controlled pulses

Cortisol/prolactin effect

Minimal

Minimal (most selective GHRP)

Research use case

GHRH axis studies

Ghrelin pathway + selective GH

Frequently Asked Questions